In the July 2025 issue of the Journal of Thoracic Oncology features an editorial: Lung Cancer in Norway, the latest in the magazine’s series, ‘Lung Cancer Worldwide’.
Editorial: Lung Cancer Worldwide Volume 20, Issue 7 p839-846 July 2025
View the paper here:
https://www.jto.org/article/S1556-0864(25)00651-3/fulltext?dgcid=raven_jbs_etoc_email
From the Epidemiology section:
The age-standardized incidence rate (ASR) of cancer in Norway is almost two times higher than the world average, owing to the relatively higher proportion of elderly inhabitants.
In the Norwegian population, the LC ASR is 55.5 and 48.5 for male and female individuals, respectively, whereas the corresponding figures are 26.1 and 23.9 for ASR (world). Compared with the period 2014 to 2018, there is a decrease in ASR for both men (−9.8%) and women (−2.8%).
Although the ASR is lower among women, the absolute annual number of new cases has been equal among the two sexes since 2018. This is due to a higher population of women among the elderly. The total number of new cases in 2023 was 3317, 1696 of which were among men and 1623 among women.
Predictions indicate that the absolute LC incidence will increase over the next decade before starting to decline, partly due to an increase in the elderly population. Median age at diagnosis is 73 years. LC is the second most frequent cancer in both sexes, after prostate and breast cancer, but by far the most common cause of cancer deaths. Owing to a steady increase in survival, the prevalence has tripled over the last 20 years, and is now 3.5 times as high as the incidence.
You can learn more about lung cancer healthcare provision in Norway by visiting our own Interactive e-Atlas
Our member organisation in Norway is lungekreftforeningen
They offer valuable information and support for people diagnosed with lung cancer and those who care about them.